Portland, OR - In a small study of bexarotene gel treatment for chronic severe hand dermatitis (HD), the medication achieved both speedy and surprising results. In a 55-patient, phase 1-2 open-label randomized clinical study of the gel, used alone and in combination with one of two steroids, 79 percent of patients on monotherapy achieved clinical improvement of at least 50 percent, and 39 percent reached at least 90 percent clearance.
Better labeling could ease confusion for patients, providers
ACD exerts an appreciable effect on quality of life, especially when it impacts a patient's hands, face, or job.
Despite two decades of warnings and education, not only do millions of Americans worship the sun at this time of year, some people can't get enough of it and are taking their desires for a deeper, darker tan a step further.
Botox manufacturer Allergan Inc.. reports it won a $1.5 million judgment in its trademark infringement and unfair competition suit against Mira Life Group Inc., according to the Associated Press.
Imaging station is solution for limited space areas
Valeant Pharmaceuticals offers intensive eye cream
BOOSTING AWARENESS
AETNA OKs psoriasis TX
PERRICONE's BOUTIQUE
Study shows alarming upward trend in teen use of indoor tanning facilities
Pimecrolimus offers effective, safe option for hand dermatitis
Several hormones are involved in the abnormal follicular exfoliation that causes acne.
Not soothing
FIGHT AGE SPOTS
NEW DOSAGE OK'D
'Simple, doable,' nbut each state must approve
Researchers looking to manipulate skin physiology to make blood vessels more vulnerable to lasers
1-Write Prescription System helps eliminateunnecessary calls from patients, pharmacists
Israelis decode gene
Face 'cradle' helps speed recovery after surgery
Educating patients makes a difference
Dermatitis' can be catch-all label for unexplainable skin conditions
Healing waters: Natural hot springs help AD sufferers
Combination of several agents may be future of AD treatment
